Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

Leukocyte count was linked to the severity of post-acute sequelae of SARS-CoV-2 infection but not of PASC occurrence or ...

When she first stepped into urgent care in early December, Maggie O'Neil wondered whether her unaccounted-for bruises and fatigue were worth the wait for a clinician. "I thought I had low iron or ...

Among postmenopausal women, leukocyte count is an independent predictor of future long COVID. HealthDay News — Leukocyte count is an independent predictor of future postacute sequelae of severe acute ...

People with shorter protective caps at the end of their chromosomes (called telomeres) may be more likely to develop ...

In South Africa, one in 15 deaths among those under 75 is caused by cancer, with blood cancer - diagnosed in over 7,300 ...

Shorter telomeres are linked to higher risks of stroke, dementia, and depression, but lifestyle factors may help counteract ...

If Maggie O'Neil can't find a bone marrow match among family members, she'll have to turn to an anonymous donor through the ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.

New study reveals that leukocyte (white blood cell) count may now be used to identify who is more likely to develop more significant disease symptoms.